Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2079PDF: 1663HTML: 366 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2472PDF: 835HTML: 8808Efremov 1: 222Efremov 2: 183 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4685PDF: 2812HTML: 2271 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3266PDF: 1336HTML: 2619 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3032PDF: 870HTML: 7161Kost Fig1: 178Kost Fig 2: 175Kost Fig3: 171Kost Fig 4: 185Kost Fig5: 183Kost fig 6: 169 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2221PDF: 873HTML: 1995Fig 1 Rossi: 173 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1347PDF: 752HTML: 940 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2553PDF: 858HTML: 17463Fig1 Caligaris: 166Fig.2 Caliga: 198 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2910PDF: 876HTML: 1593 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3905PDF: 1484HTML: 9184Untitled: 273Untitled: 176Untitled: 163Untitled: 160Untitled: 176Untitled: 332 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1628PDF: 1167HTML: 193 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2783PDF: 1002HTML: 5513 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2268PDF: 1318HTML: 17074Bassan Fig.1: 140Bassan Fig.2: 151Bassan Fig.4: 138Fig.3: 179 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4051PDF: 3342HTML: 198 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4036PDF: 1917HTML: 5217Table 1: 183 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3506PDF: 1547HTML: 75 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1649PDF: 643HTML: 2427 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1600PDF: 1085HTML: 111 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2208PDF: 1037HTML: 1977Characteristic of study group: 196 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1349HTML: 386PDF: 812 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
676PDF: 364Suppl. Files: 117HTML: 107 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4074PDF: 1576HTML: 928 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2304PDF: 978HTML: 7612Untitled: 272Fig2: 182Fig3: 166Fig4: 178 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3143PDF: 888HTML: 1529Fig.1 CHL-R paper: 211Fig 2 CHL-R paper: 233 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1452PDF: 761HTML: 198 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3731PDF: 1465HTML: 478Figures . Eliassian: 216 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1305PDF: 803HTML: 124 -
Osteolytic bone lesions – A rare presentation of AML M6.
1961PDF: 1090HTML: 7915Untitled: 202







